OCLN gene variants identified in three patients with severe neurodevelopmental disorder associated with epilepsy,

Tulay Oncu Oner1, Aycan Unalp2, Semra Hiz3

  • 1Department of Medical Biology and Genetics, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

Insights

Homozygous variants in the OCLN gene cause band-like calcification with simplified gyration and polymicrogyria (BLC-PMG), a condition characterized by severe developmental delay. This study identifies new OCLN variants, expanding the known genetic causes of BLC-PMG.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Band-like calcification with simplified gyration and polymicrogyria (BLC-PMG) is a rare genetic disorder.
  • It is characterized by microcephaly, intracranial calcification, and severe developmental delay.
  • The OCLN gene, encoding the occludin protein, has been implicated in BLC-PMG.

Purpose of the Study:

  • To report three new cases of BLC-PMG caused by homozygous OCLN variants.
  • To expand the spectrum of OCLN gene variants associated with BLC-PMG.
  • To investigate potential genotype-phenotype correlations, including renal failure.

Main Methods:

  • Trio-whole exome sequencing (Trio-WES) was used for variant identification.
  • In silico tools were employed to assess the pathogenicity of identified variants.
  • Clinical features of the affected individuals were documented and compared to existing literature.

Main Results:

  • Two consanguineous families with BLC-PMG were identified, harboring homozygous OCLN variants.
  • A previously reported frameshift variant was found in two cases, and a novel missense variant was identified in another case.
  • All cases presented with core BLC-PMG features; two cases with the frameshift variant also exhibited renal failure.

Conclusions:

  • Homozygous OCLN variants are a significant cause of BLC-PMG.
  • A specific frameshift OCLN variant may be associated with a distinct phenotype including renal failure, particularly in Turkish populations.
  • These findings contribute to the molecular diagnosis and understanding of BLC-PMG.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
361
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
676
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
103.7K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
810
Genetic Lingo01:11

Genetic Lingo

Overview
106.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
521